Word

SPLENDRIS

Status

Dead

Status Code

404

Status Date

Sunday, May 7, 2023

Serial Number

79136686

Registration Number

4642937

Registration Date

Tuesday, November 25, 2014

Mark Type

4000

Filing Date

Tuesday, May 7, 2013

Published for Opposition

Tuesday, September 9, 2014

Cancellation Date

Monday, May 8, 2023

Trademark Owner History

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. - Original Registrant
SHENZHEN SALUBRIS; PHARMACEUTICALS CO.,LTD. - Original Applicant

Classifications

5 Pharmaceutical preparations, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Chemico-pharmaceutical preparations, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; Chemical preparations for pharmaceutical purposes, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Medicines for human purposes, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Medicated troches, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Prepared Chinese medicines, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Biochemical medicines, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Dietetic substances adapted for medical use, namely, beverages or food in the nature of vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, and mineral food-supplements, which are used for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Drugs for medical purposes, namely, medicines for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders

Trademark Events

Nov 26, 2023

Notification Of Effect Of Cancellation Of Intl Reg E-Mailed

Nov 26, 2023

Death Of International Registration

Jul 11, 2022

Total Invalidation Processed By The Ib

Jun 9, 2022

Generic Madrid Transaction Sent To Ib

Jun 8, 2022

Generic Madrid Transaction Created

Feb 11, 2022

Total Invalidation Of Reg Ext Protection Created

Jun 11, 2021

Cancelled Section 71

Nov 25, 2019

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Oct 9, 2019

Correction From The Ib Examined, No Action Is Needed

Jul 5, 2019

Correction Transaction Received From Ib

Jul 4, 2019

New Representative At Ib Received

Dec 7, 2018

New Representative At Ib Received

May 8, 2015

Final Decision Transaction Processed By Ib

Apr 20, 2015

Final Disposition Notice Sent To Ib

Apr 20, 2015

Final Disposition Processed

Mar 12, 2015

Teas Change Of Correspondence Received

Feb 25, 2015

Final Disposition Notice Created, To Be Sent To Ib

Nov 25, 2014

Registered-Principal Register

Sep 9, 2014

Official Gazette Publication Confirmation E-Mailed

Sep 9, 2014

Published For Opposition

Aug 20, 2014

Notification Of Notice Of Publication E-Mailed

Aug 7, 2014

New Representative At Ib Received

Aug 5, 2014

Law Office Publication Review Completed

Aug 5, 2014

Assigned To Lie

Jul 27, 2014

Approved For Pub - Principal Register

Jul 27, 2014

Examiner's Amendment Entered

Jul 27, 2014

Notification Of Examiners Amendment E-Mailed

Jul 27, 2014

Examiners Amendment E-Mailed

Jul 27, 2014

Examiners Amendment -Written

Jun 11, 2014

Teas/Email Correspondence Entered

Jun 11, 2014

Correspondence Received In Law Office

Jun 11, 2014

Teas Request For Reconsideration Received

Dec 17, 2013

Final Refusal Mailed

Dec 16, 2013

Final Refusal Written

Nov 20, 2013

Teas/Email Correspondence Entered

Nov 20, 2013

Correspondence Received In Law Office

Nov 20, 2013

Teas Response To Office Action Received

Nov 14, 2013

Refusal Processed By Ib

Oct 23, 2013

Non-Final Action Mailed - Refusal Sent To Ib

Oct 22, 2013

Refusal Processed By Mpu

Oct 21, 2013

Non-Final Action (Ib Refusal) Prepared For Review

Oct 20, 2013

Non-Final Action Written

Oct 16, 2013

Application Filing Receipt Mailed

Oct 13, 2013

Assigned To Examiner

Oct 12, 2013

New Application Office Supplied Data Entered

Oct 10, 2013

Sn Assigned For Sect 66a Appl From Ib